Common birth control drug may up risk of HIV

Image
IANS Johannesburg
Last Updated : Jan 05 2018 | 4:25 PM IST

Taking a popular injectable contraceptive drug is likely to increase the risk of developing HIV infection by 40 per cent, claims a study.

The contraceptive depot-medroxyprogesterone acetate (DMPA) is an injectables birth control shot that works by releasing the hormone progestin into the body which prevents the ovaries from releasing eggs and thickens the mucous layer around the cervix to block sperm from getting through.

In the study, researchers from the University of Cape Town in South Africa, examined animal, cell and biochemical research on the form of progestin used in DMPA -- medroxprogesterone acetate, or MPA.

Their analysis, published in the journal Endocrine Reviews, revealed that MPA acts differently than other forms of progestin used in contraceptives.

MPA behaves like the stress hormone cortisol in the cells of the genital tract that can come in contact with HIV.

Other reasons include decreased immune function and the protective barrier function of the female genital tract, said lead author, Janet P. Hapgood, Professor at the varsity

"Studying the biology of MPA helps us understand what may be driving the increased rate of HIV infection seen in human research," she said.

"Increasing availability of contraceptives that use a different form of the female hormone progestin than the one found in DMPA could help reduce the risk of HIV transmission," Hapgood added.

In 2016, there were 36.7 million people worldwide were living with HIV, according to UNAIDS -- Joint United Nations Programme on HIV/AIDS. AIDS is the most advanced stage of HIV infection.

In 2015, India had approved the use of DMPA and recommended its inclusion in the national family planning programme and administered free of cost once every three months, usually on the upper arm or the buttocks.

Previously, the use of DMPA have been associated with many health problems in women including menstrual irregularity, demineralisation of bones, abdominal bloating and discomfort, mood changes, decreased sex drive, etc.

--IANS

rt/qd/vd

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 05 2018 | 4:18 PM IST

Next Story